/ Not yet recruitingPhase 3 An open, randomized, parallel-group trial of the efficacy and safety of the RB-2410113 medicinal product versus a reference product in patients with seasonal allergic rhinitis - Mometasone Furoate
/ Not yet recruitingPhase 3 An open, randomized, parallel-group trial of the efficacy and safety of RB-2410114 medicinal product versus a reference product in patients with seasonal allergic rhinitis
/ Not yet recruitingNot Applicable An International, Open, Randomized, Comparative study of the efficacy and safety of the medicinal products Glycopyrronium bromide plus Indacaterol 50 plus 110 μg inhalation powder capsules (PSK Pharma LLC, Russia) and Ultibro Breezhaler 50 plus 110μg inhalation powder capsules(Novartis Pharma AG, Switzerland) in subjects with COPD
100 Clinical Results associated with PSK Pharma LLC
0 Patents (Medical) associated with PSK Pharma LLC
100 Deals associated with PSK Pharma LLC
100 Translational Medicine associated with PSK Pharma LLC